Evidence map›Paper›PMID 35458561›Full record

ArticleViruses2022

Two Novel Lytic Bacteriophages Infecting

Pavel V Tkachev, Ivan M Pchelin, Daniil V Azarov, Andrey N Gorshkov, Olga V Shamova, Alexander V Dmitriev, Artemiy E Goncharov

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Enterococcal Phages: Food and Health Applications.Antibiotics (Basel, Switzerland) · 2023
    Review
  8. Article
  9. A Genome of TemperateViruses · 2023
    Article
  10. Vancomycin Resistance inMicroorganisms · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pavel V TkachevScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.ORCID 0000-0002-8028-8643
Ivan M PchelinScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.ORCID 0000-0003-3062-3316
Daniil V AzarovScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
Andrey N GorshkovSmorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.ORCID 0000-0003-2303-1144
Olga V ShamovaScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
Alexander V DmitrievScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
Artemiy E GoncharovScientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the WCRC "Center for Personalized Medicine", Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.ORCID 0000-0002-5206-6656
Institute of Experimental Medicine · RUFederal Almazov North-West Medical Research Centre · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of antibiotic resistance is of major concern globally. Among the most worrying pathogenic bacteria are vancomycin-resistant enterococci. Phage therapy is a highly promising method for controlling enterococcal infections. In this study, we described two virulent tailed bacteriophages possessing lytic activity against

Indexed as

BacteriophagesGram-Positive Bacterial InfectionsPhage TherapySiphoviridaeAnimalsAnti-Bacterial AgentsEnterococcusEnterococcus faecalisMicrobial Sensitivity TestsAnti-Bacterial AgentsbacteriophageEnterococcus virusphage therapy

Identifiers

PMID35458561
PMCPMC9030284
OpenAlexW4224246902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.